Screener · short volume
Short volume screener
Screen US-listed companies by FINRA daily short volume. Filter by market cap, sector, and industry, and sort by short %, short volume, total volume, or market cap.
1D · FINRA Reg SHO · as of Apr 27, 2026
| # | Ticker | Company | Sector | Market cap | Short | Total | Short % |
|---|---|---|---|---|---|---|---|
| 1 | BLLN | BillionToOne Inc. | Health CareMedical Specialities | $3.76B | 99.9K | 110.0K | 90.8% |
| 2 | UFPT | UFP Technologies Inc. | Health CareMedical/Dental Instruments | $1.52B | 157.3K | 179.1K | 87.8% |
| 3 | DMRA | Damora Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.54B | 121.1K | 138.9K | 87.1% |
| 4 | LIVN | LivaNova PLC | Health CareBiotechnology: Electromedical & Electrotherapeutic Apparatus | $3.47B | 208.4K | 251.2K | 82.9% |
| 5 | CRNX | Crinetics Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $4.04B | 297.1K | 360.4K | 82.4% |
| 6 | IMVT | Immunovant Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $5.83B | 275.9K | 335.1K | 82.3% |
| 7 | KRYS | Krystal Biotech Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $8.03B | 85.2K | 103.8K | 82.1% |
| 8 | LNTH | Lantheus Holdings Inc. | Health CareBiotechnology: In Vitro & In Vivo Diagnostic Substances | $5.46B | 187.0K | 230.1K | 81.3% |
| 9 | GENB | Generate Biomedicines Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.59B | 98.8K | 122.0K | 81.0% |
| 10 | PHAT | Phathom Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $920.6M | 454.4K | 562.1K | 80.8% |
| 11 | BLCO | Bausch + Lomb Corporation | Health CareOphthalmic Goods | $5.66B | 116.9K | 145.3K | 80.4% |
| 12 | HOWL | Werewolf Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $40.3M | 183.4K | 234.0K | 78.4% |
| 13 | VCYT | Veracyte Inc. | Health CareMedical Specialities | $2.70B | 135.3K | 173.0K | 78.2% |
| 14 | SION | Sionna Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.76B | 251.0K | 320.9K | 78.2% |
| 15 | INCY | Incyte Corp. | Health CareBiotechnology: Commercial Physical & Biological Resarch | $19.05B | 634.0K | 810.9K | 78.2% |
| 16 | PRKS | United Parks & Resorts Inc. | Health CareBiotechnology: Electromedical & Electrotherapeutic Apparatus | $1.67B | 167.1K | 213.9K | 78.1% |
| 17 | MYO | Myomo Inc. | Health CareIndustrial Specialties | $32.0M | 112.9K | 146.6K | 77.1% |
| 18 | NUS | Nu Skin Enterprises Inc. | Health CareOther Pharmaceuticals | $367.8M | 92.8K | 120.6K | 77.0% |
| 19 | MEDP | Medpace Holdings Inc. | Health CareBiotechnology: Commercial Physical & Biological Resarch | $12.03B | 138.7K | 180.5K | 76.8% |
| 20 | KLRA | Kailera Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $2.89B | 415.9K | 544.2K | 76.4% |
| 21 | ITGR | Integer Holdings Corporation | Health CareBiotechnology: Electromedical & Electrotherapeutic Apparatus | $2.91B | 166.7K | 218.7K | 76.2% |
| 22 | AMPH | Amphastar Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $964.2M | 81.0K | 107.1K | 75.6% |
| 23 | LGND | Ligand Pharmaceuticals Incorporated | Health CareBiotechnology: Pharmaceutical Preparations | $4.85B | 83.8K | 111.8K | 74.9% |
| 24 | PBH | Prestige Consumer Healthcare Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $2.76B | 197.4K | 263.5K | 74.9% |
| 25 | PRCT | PROCEPT BioRobotics Corporation | Health CareMedical/Dental Instruments | $1.37B | 344.5K | 461.8K | 74.6% |
| 26 | NRXP | NRX Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $100.2M | 594.6K | 801.1K | 74.2% |
| 27 | HALO | Halozyme Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $7.64B | 411.9K | 555.4K | 74.2% |
| 28 | FDMT | 4D Molecular Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $482.4M | 129.1K | 174.5K | 74.0% |
| 29 | PGNY | Progyny Inc. | Health CareMisc Health and Biotechnology Services | $1.44B | 402.1K | 544.2K | 73.9% |
| 30 | HURA | TuHURA Biosciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $141.1M | 308.3K | 417.7K | 73.8% |
| 31 | HSIC | Henry Schein Inc. | Health CareMedical Specialities | $8.86B | 337.8K | 459.3K | 73.5% |
| 32 | LUCD | Lucid Diagnostics Inc. | Health CareMedical/Dental Instruments | $187.9M | 341.7K | 465.0K | 73.5% |
| 33 | AMGN | Amgen Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $183.59B | 607.4K | 827.5K | 73.4% |
| 34 | FOLD | Amicus Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $4.55B | 1.18M | 1.61M | 73.2% |
| 35 | HUM | Humana Inc. | Health CareMedical Specialities | $26.97B | 408.7K | 559.3K | 73.1% |
| 36 | KYMR | Kymera Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $7.08B | 129.4K | 177.3K | 73.0% |
| 37 | KROS | Keros Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $217.9M | 84.2K | 115.4K | 73.0% |
| 38 | BVS | Bioventus Inc. | Health CareMedical/Dental Instruments | $835.1M | 88.6K | 121.4K | 73.0% |
| 39 | LH | Labcorp Holdings Inc. | Health CareMedical Specialities | $21.65B | 145.8K | 200.0K | 72.9% |
| 40 | NUVB | Nuvation Bio Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.59B | 2.67M | 3.67M | 72.7% |
| 41 | CTMX | CytomX Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $730.1M | 823.9K | 1.14M | 72.4% |
| 42 | DRTS | Alpha Tau Medical Ltd. | Health CareMedical/Dental Instruments | $696.2M | 127.3K | 177.2K | 71.9% |
| 43 | FTRE | Fortrea Holdings Inc. | Health CareMedical Specialities | $991.1M | 642.9K | 896.6K | 71.7% |
| 44 | GLUE | Monte Rosa Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $1.54B | 130.8K | 182.6K | 71.7% |
| 45 | IDXX | IDEXX Laboratories Inc. | Health CareBiotechnology: In Vitro & In Vivo Diagnostic Substances | $45.72B | 176.2K | 246.2K | 71.6% |
| 46 | MPLT | MapLight Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.30B | 134.5K | 188.4K | 71.4% |
| 47 | AIM | AIM ImmunoTech Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $4.2M | 119.2K | 167.7K | 71.1% |
| 48 | OLMA | Olema Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.33B | 145.4K | 207.1K | 70.2% |
| 49 | RGEN | Repligen Corporation | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $6.67B | 178.4K | 254.3K | 70.2% |
| 50 | GMAB | Genmab A/S | Health CareBiotechnology: Pharmaceutical Preparations | $17.11B | 176.9K | 253.0K | 69.9% |
| 51 | PMI | Picard Medical Inc. | Health CareMedical/Dental Instruments | $51.9M | 82.1K | 118.1K | 69.5% |
| 52 | ACHV | Achieve Life Sciences Inc. | Health CareBiotechnology: In Vitro & In Vivo Diagnostic Substances | $210.8M | 254.7K | 366.6K | 69.5% |
| 53 | PCRX | Pacira BioSciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.03B | 76.8K | 110.7K | 69.4% |
| 54 | WRBY | Warby Parker Inc. | Health CareOphthalmic Goods | $2.85B | 384.1K | 557.9K | 68.8% |
| 55 | PGEN | Precigen Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.40B | 666.0K | 971.3K | 68.6% |
| 56 | ARWR | Arrowhead Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $10.31B | 360.0K | 526.7K | 68.3% |
| 57 | DGX | Quest Diagnostics Incorporated | Health CareMedical Specialities | $21.77B | 211.2K | 310.2K | 68.1% |
| 58 | OPCH | Option Care Health Inc. | Health CareMedical/Nursing Services | $4.38B | 410.5K | 603.9K | 68.0% |
| 59 | LENZ | LENZ Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $306.0M | 200.5K | 295.2K | 67.9% |
| 60 | CTXR | Citius Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $15.5M | 850.3K | 1.26M | 67.6% |
| 61 | PROK | ProKidney Corp. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $561.7M | 169.8K | 252.3K | 67.3% |
| 62 | NVST | Envista Holdings Corporation | Health CareMedical/Dental Instruments | $4.36B | 404.5K | 604.1K | 67.0% |
| 63 | ZBH | Zimmer Biomet Holdings Inc. | Health CareIndustrial Specialties | $17.92B | 765.7K | 1.14M | 66.9% |
| 64 | MAIA | MAIA Biotechnology Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $75.2M | 269.9K | 403.7K | 66.9% |
| 65 | ASND | Ascendis Pharma A/S | Health CareBiotechnology: Pharmaceutical Preparations | $14.05B | 235.4K | 353.0K | 66.7% |
| 66 | MNKD | MannKind Corporation | Health CareBiotechnology: Pharmaceutical Preparations | $812.1M | 1.31M | 1.96M | 66.7% |
| 67 | SOLV | Solventum Corporation | Health CareMedical/Dental Instruments | $12.10B | 250.1K | 375.5K | 66.6% |
| 68 | HCA | HCA Healthcare Inc. | Health CareHospital/Nursing Management | $99.66B | 391.3K | 587.6K | 66.6% |
| 69 | CGEN | Compugen Ltd. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $276.1M | 255.2K | 383.8K | 66.5% |
| 70 | BBOT | BridgeBio Oncology Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $703.5M | 228.0K | 343.5K | 66.4% |
| 71 | VTRS | Viatris Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $17.25B | 1.38M | 2.08M | 66.3% |
| 72 | ALC | Alcon Inc. | Health CareOphthalmic Goods | $37.98B | 308.9K | 466.9K | 66.2% |
| 73 | NRIX | Nurix Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.71B | 125.9K | 190.4K | 66.1% |
| 74 | KPTI | Karyopharm Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $195.2M | 106.9K | 161.7K | 66.1% |
| 75 | ZBIO | Zenas BioPharma Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.07B | 99.8K | 151.1K | 66.1% |
| 76 | ILMN | Illumina Inc. | Health CareMedical Specialities | $19.52B | 342.8K | 518.9K | 66.1% |
| 77 | RMD | ResMed Inc. | Health CareMedical/Dental Instruments | $32.34B | 364.5K | 552.1K | 66.0% |
| 78 | NTLA | Intellia Therapeutics Inc. | Health CareBiotechnology: In Vitro & In Vivo Diagnostic Substances | $1.54B | 6.28M | 9.51M | 66.0% |
| 79 | DNLI | Denali Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $3.16B | 190.8K | 290.2K | 65.7% |
| 80 | INBX | Inhibrx Biosciences Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $1.92B | 136.5K | 207.8K | 65.7% |
| 81 | ENGN | enGene Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $482.3M | 362.1K | 551.7K | 65.6% |
| 82 | MIRM | Mirum Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $5.64B | 116.8K | 178.0K | 65.6% |
| 83 | CDNA | CareDx Inc. | Health CareMedical Specialities | $1.12B | 160.9K | 245.2K | 65.6% |
| 84 | GMED | Globus Medical Inc. | Health CareMedical/Dental Instruments | $12.67B | 212.9K | 325.7K | 65.4% |
| 85 | ISPC | iSpecimen Inc. | Health CareBiotechnology: Commercial Physical & Biological Resarch | $3.7M | 3.71M | 5.68M | 65.3% |
| 86 | PTCT | PTC Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $5.74B | 150.6K | 230.7K | 65.3% |
| 87 | URGN | UroGen Pharma Ltd. | Health CareBiotechnology: Pharmaceutical Preparations | $1.16B | 97.6K | 149.7K | 65.2% |
| 88 | NEOG | Neogen Corporation | Health CareBiotechnology: In Vitro & In Vivo Diagnostic Substances | $2.06B | 293.9K | 451.5K | 65.1% |
| 89 | CAI | Caris Life Sciences Inc. | Health CareMedical Specialities | $971.9M | 319.1K | 490.6K | 65.0% |
| 90 | NXGL | NexGel Inc | Health CareMedical/Dental Instruments | $5.1M | 107.0K | 164.6K | 65.0% |
| 91 | NEO | NeoGenomics Inc. | Health CarePrecision Instruments | $1.12B | 521.3K | 806.9K | 64.6% |
| 92 | GH | Guardant Health Inc. | Health CareMedical Specialities | $11.61B | 392.2K | 607.7K | 64.6% |
| 93 | SIBN | SI-BONE Inc. | Health CareMedical/Dental Instruments | $581.2M | 114.0K | 176.8K | 64.5% |
| 94 | IDYA | IDEAYA Biosciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $2.59B | 221.1K | 343.1K | 64.5% |
| 95 | ALKS | Alkermes plc | Health CareBiotechnology: Pharmaceutical Preparations | $5.61B | 249.0K | 389.8K | 63.9% |
| 96 | NKTR | Nektar Therapeutics | Health CareBiotechnology: Pharmaceutical Preparations | $2.57B | 445.2K | 697.0K | 63.9% |
| 97 | MDLN | Medline Inc. | Health CareMedical/Dental Instruments | $59.42B | 710.8K | 1.11M | 63.8% |
| 98 | ONCY | Oncolytics Biotech Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $104.6M | 2.03M | 3.18M | 63.8% |
| 99 | MBX | MBX Biosciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.52B | 110.0K | 172.6K | 63.7% |
| 100 | SGRY | Surgery Partners Inc. | Health CareHospital/Nursing Management | $1.90B | 191.0K | 299.8K | 63.7% |